miR-19b-3p工程化脂肪源干细胞外体减轻急性肝衰竭通过促进组织修复和微环境重塑
Baitong Wu1, Jiuxing Feng2,3, Xi Wang4
1East Hospital, Stem Cell Research Center, School of Medicine, Tongji University, Shanghai, 200120, China.
Materials today. Bio
|January 21, 2026
概括
携带miR-19b-3p的工程外体通过减少炎症和氧化应激,在急性肝衰竭 (ALF) 模型中显著提高了生存率,提供了一种新的治疗方法.
科学领域:
- 再生医学是一种再生医学.
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 急性肝衰竭 (ALF) 是一种严重的疾病,治疗选择有限.
- 脂肪基衍生干细胞 (ADSC) 和它们的外体细胞 (ADSC-EXO) 显示出通过近效应的组织修复的前景.
研究的目的:
- 开发一个基于ADSC-EXO的ALF治疗策略.
- 研究miR-19b-3p在改善ALF中的作用.
主要方法:
- ADSC-EXO与miR-19b-3p (miR-19-EXO) 的功能化.
- 在ALF模型中使用miR-19-EXO.
- 评估生存率,肝功能,组织学和炎症标志物.
- 涉及p47phox,NADPH氧化酶,NF-κB通路和巨细胞两极分化的机制研究.
主要成果:
- 在ALF模型中,miR-19-EXO的使用使生存率从25%提高到75%.
- 治疗逆转了肝功能,改善了组织结构,并减少了炎症.
- miR-19b-3p针对p47phox,减少氧化应激并抑制NF-κB通路.
- 与其他输送方法和ROS清理器相比,miR-19-EXO显示出更高的疗效.
结论:
- 携带miR-19b-3p的工程ADSC-EXO代表了ALF的有希望的治疗策略.
- 这种方法同时重建肝脏的微环境,并促进组织修复.
- 这些发现支持开发工程外体,用于有针对性的ALF干预.
更多相关视频
07:09Isolation of Murine Adipose Tissue-derived Microvascular Fragments as Vascularization Units for Tissue Engineering
Published on: April 30, 2017
12.9K
06:00Isolation and Culture of Human Adipose-Derived Stem Cells With an Innovative Xenogeneic-Free Method for Human Therapy
Published on: February 3, 2023
4.1K
相关概念视频
Acute Respiratory Failure-I
901
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
901
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-V
476
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
476
Acute Respiratory Failure-III
811
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
811
Acute Respiratory Failure-IV
526
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
526
Transcription Attenuation in Prokaryotes
18.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.2K
